Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 29:79:100524.
doi: 10.1016/j.clinsp.2024.100524. eCollection 2024.

Polymorphisms of the SERPINA1 gene are associated with higher mortality in a Brazilian cohort of ANCA-associated vasculitis patients

Affiliations

Polymorphisms of the SERPINA1 gene are associated with higher mortality in a Brazilian cohort of ANCA-associated vasculitis patients

Henrique Ayres Mayrink Giardini et al. Clinics (Sao Paulo). .

Abstract

Background: Alpha-1-Antitrypsin (A1AT) is a protease inhibitor encoded by the SERPINA1 gene. A1AT serves as the primary natural inhibitor of Proteinase 3 (PR3), an enzyme found in neutrophils. PR3 is an antigenic target of Anti-Neutrophil Cytoplasmic Antibodies (ANCA). While numerous studies have established a connection between Single Nucleotide Polymorphisms (SNPs) in the SERPINA1 gene and ANCA-Associated Vasculitis (AAV), limited research has delved into the impact of these polymorphisms on the prognosis of these patients.

Objective: The present study's objective is to investigate mortality disparities among Brazilian AAV patients carrying SERPINA1 SNPs (rs7151526, rs28929454) compared to non-carriers. Additionally, the authors analyzed demographic, clinical, and serologic data in these two groups.

Methods: In this single-center prospective cohort study, the authors enrolled AAV patients who were monitored for a duration of up to three years. The identification of SNPs was conducted through RT-PCR. Survival analysis, including Kaplan-Meier survival curves, and Cox proportional regression analysis was subsequently performed to evaluate outcomes.

Results: The authors assessed 115 patients (65.2% with granulomatosis with polyangiitis, 17.4% with eosinophilic granulomatosis with polyangiitis, and 17.4% with microscopic polyangiitis). All patients were aged ≥ 18 years, with 37.4% being female, and 54.7% identified as White. The association between SERPINA1 SNPs proved to be the most significant factor linked to mortality in the cohort (HR = 6.2, 95% CI 1.4‒27.1, p = 0.015). SERPINA1 SNP carriers exhibited a lower mean survival [rs7151526: 57.4 (42.7‒72.2) years, p < 0.007; rs28929454: 54.9 (40.9‒68.9) years, p < 0.0001] than non-carriers (68.0 [67.2‒69.0] years).

Conclusion: SERPINA1 SNPs are associated with increased mortality in Brazilian AAV patients.

Keywords: Gene; Mortality; Polymorphism; Systemic vasculitis.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare no conflicts of interest.

Figures

Fig 1
Fig. 1
Cox proportional hazard model: genetic factor and comorbidities. HR, Hazard Ratio; CI, Confidence Interval. The analysis of the association of the SNPs of the SERPINA1 gene was performed due to the linkage disequilibrium between them (association coefficient 0.88, p < 0.001). Statistically significant: p-value < 0.05.

References

    1. Watts R.A., Mahr A., Mohammad A.J., Gatenby P., Basu N., Flores-Suárez L.F. Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Nephrol Dial Transplant. 2015;30(1):i14–i22. Suppl. - PubMed
    1. Watts R.A., Hatemi G., Burns J.C., Mohammad A.J. Global epidemiology of vasculitis. Nat Rev Rheumatol. 2022;18(1):22–34. - PMC - PubMed
    1. Xie G., Roshandel D., Sherva R., Monach P.A., Lu E.Y., Kung T., et al. Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1×04 and SEMA6A gene variants: evidence from genome-wide analysis. Arthritis Rheum. 2013;65(9):2457–2468. - PMC - PubMed
    1. Nakazawa D., Masuda S., Tomaru U. Ishizu A. Pathogenesis and therapeutic interventions for ANCA-associated vasculitis. Nat Rev Rheumatol. 2019;15(2):91–101. - PubMed
    1. Cornec D., Cornec-Le Gall E., Fervenza F.C. Specks U. ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients. Nat Rev Rheumatol. 2016;12(10):570–579. - PubMed

Publication types

Substances

LinkOut - more resources